Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AUTL compared with PATH: revenue, margins and what each company keeps, and the suppliers and customers both name
AUTL
Autolus Therapeutics plc
Change
Mkt cap
Revenue
Revenue
PATH
UiPath, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AUTL
Autolus Therapeutics plc
vs
PATH
UiPath, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AUTL: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AUTL, solid
PATH, dashed
AUTL
Autolus Therapeutics plc
Change
1.51
▼
−4.43%
· post 1.51
Mkt cap
$404.6M
Revenue
$46M
Q2 FY26
Revenue
$75M
FY25
PATH
UiPath, Inc.
Change
13.72
▼
−0.46%
· post 13.71
Closed
Oct 30 '26
Mkt cap
$7.2B
Revenue
$410M
Q2 FY27
Revenue
$1.6B
FY26
vs
Compare
Closed
Oct 30 '26
AUTL
Autolus Therapeutics plc
vs
PATH
UiPath, Inc.
1.51
▼
−4.43%
post 1.51
Price
13.72
▼
−0.46%
post 13.71
$404.6M
Mkt cap
$7.2B
Q2 FY26
$46M
Revenue
$410M
Q2 FY27
FY25
$75M
Revenue
$1.6B
FY26
Change
Change
AUTL
1.51
▼
−4.43%
vs
PATH
13.72
▼
−0.46%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AUTL
4
MRNA
Moderna
customer
BNTX
BioNTech
customer
—
Miltenyi Biotec GmbH
unlisted
supplier
—
University College of London Business
unlisted
supplier
Shared
0
No disclosed counterparties: PATH.
Only PATH
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR